Discrimination Between Patients With Alzheimer Disease and Healthy Subjects Using Layer Analysis of Cerebral Blood Flow and Xenon Solubility Coefficient in Xenon-Enhanced Computed Tomography

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of computer assisted tomography

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/RCT.0000000000000525PMID 28505626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of blood flow and xenon solubility coefficient in the human liver by xenon-enhanced computed tomography.

  2012cited by this paper
• Alzheimer's disease: strategies for disease modification

  2010cited by this paper
• 320-slice CT neuroimaging: initial clinical experience and image quality evaluation.

  2009cited by this paper
• Computed tomography dose assessment for a 160 mm wide, 320 detector row, cone beam CT scanner

  2009cited by this paper
• Determination of time-course change rate for arterial xenon using the time course of tissue xenon concentration in xenon-enhanced computed tomography.

  2008cited by this paper
• Volume CT: state-of-the-art reporting.

  2007cited by this paper
• Discrepancy of xenon concentrations between end-tidal and blood collection methods in xenon-enhanced computed tomographic measurement of cerebral blood flow

  2004cited by this paper
• Alzheimer's disease.

  2004cited by this paper
• Quantitative Cerebral Blood Flow Calculation Method Using White Matter Lambda in Xenon CT

  2002cited by this paper
• Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography

  1997cited by this paper
• Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.

  1992cited by this paper
• Functional Brain Imaging and Alzheimer-Type Dementia

  1991cited by this paper
• Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.

  1991cited by this paper
• Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PET a

  1991cited by this paper
• Criteria for the Diagnosis of Alzheimer's Disease with Positron Emission Tomography

  1990cited by this paper
• Thalamic and subcortical gliosis with dementia.

  1987cited by this paper
• Dominantly inherited Alzheimer's disease: cerebral glucose metabolism.

  1987cited by this paper
• Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.

  1986cited by this paper
• Positron emission tomography in Alzheimer's disease

  1986cited by this paper
• In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography.

  1982cited by this paper
• Local Cerebral Blood Flow Values as Estimated with Diffusible Tracers: Validity of Assumptions in Normal and Ischemic Tissue

  1981cited by this paper
• Local cerebral blood flow measured by CT after stable xenon inhalation.

  1980cited by this paper
• Solubility coefficients for inhaled anaesthetics for water, oil and biological media.

  1973cited by this paper
• The Partition of Trace Amounts of Xenon Between Human Blood and Brain Tissues at 37?C

  1965cited by this paper

• Altered cerebral blood flow in older adults with Alzheimer’s disease: a systematic review

  2022cites this paper
• Noble gas and neuroprotection: From bench to bedside

  2022cites this paper
• Multi-Energy Computed Tomography and Material Quantification: Current Barriers and Opportunities for Advancement.

  2020cites this paper
• 6-Hydroxy-l-Nicotine and Memory Impairment

  2019cites this paper
• Discrimination between patients with mild Alzheimer's disease and healthy subjects based on cerebral blood flow images of the lateral views in xenon‐enhanced computed tomography

  2018cites this paper
• 2分吸入キセノンCTによる，認知症患者の脳血流量評価：キセノン吸入時間短縮による患者への負担軽減の試み

  2018cites this paper